Subcutaneous Insulin for DKA

In the U.S. most DKA is managed in the ED with IV insulin drips, but short acting subcutaneous regimens can be just as effective. The subcutaneous regimen should utilize asparte not regular insulin and requires dosing at 1hr or 2 hour intervals depending on the chosen protocol.  The subQ regimen is more utilized in Europe but is worth discussing with your pharmacist in order to have an alternative means of managing a DKA patient.

Leave a Reply